| Outcome Measures: |
Primary: Specify incidence rates of adverse drug reactions associated with a decrease in body fluids and their risk factors, Up to 12 months | Secondary: Investigate the occurrence of urinary tract infection, 1-month, 3-month, 6-month, 9-month and 12-month (or at treatment discontinuation time)|Investigate the occurrence of adverse drug reactions in patients at a high risk (those who have poorly controlled blood sugar levels, concurrent organic abnormalities in the urinary system, advanced diabetic neuropathy, etc)., 1-month, 3-month, 6-month, 9-month and 12-month (or at treatment discontinuation time)|Investigate the occurrence of adverse drug reactions other than the above, 1-month, 3-month, 6-month, 9-month and 12-month (or at treatment discontinuation time)
|
| Locations: |
Chubu, Japan|Chugoku, Japan|Hokkaido, Japan|Kansai, Japan|Kantou, Japan|Kyusyu, Japan|Shikoku, Japan|Tohoku, Japan
|
